Month: June 2023

Perspective Therapeutics’ Cesium-131 Featured at the American Brachytherapy Society’s Annual Conference

The presentation entitled Prostate Brachytherapy with Cs-131: Long Term Results Compared to Published SBRT Data, by authors Mohammed A. Mohammed, MD, Ronald M. Benoit, Sushil Beriwal, MD, and Ryan P. Smith, MD was presented by Ryan P. Smith…

Perspective Therapeutics Initiates Phase 1/2a Clinical Trials for Two Targeted Alpha Therapy Oncology Product Candidates

VMT-α-NET for neuroendocrine cancers and VMT01 for melanoma are both entering therapeutic trials under IND at leading US institutions…

Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point

Authors: R. Yaparpalvi, J. Rossinow, W.A. Cavanagh, W. Choi1, L. Minsky, N. Kahan1, W. Bodner, M. Garg, S. Kalnicki, C. Guha

Scroll to top